載入...
Is completion axillary lymph node dissection necessary in patients who are underrepresented in the ACOSOG Z0011 trial?
PURPOSE: The American College of Surgeons Oncology Group trial Z0011 demonstrated that axillary node dissection (ALND) can be omitted in patients managed with breast conserving surgery and 1 to 2 positive sentinel lymph nodes (SLNs) without adverse effects on locoregional recurrence or disease-free...
Na minha lista:
| 發表在: | Adv Radiat Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6127974/ https://ncbi.nlm.nih.gov/pubmed/30197938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.adro.2018.03.004 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|